Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

AJOVY

FREMANEZUMAB-VFRM

Standard Dose
150MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary

Approval overview AJOVY is listed in Drugs@FDA under application 761089 (BLA).

Review priority: PRIORITY Marketing status: Prescription Active ingredient FREMANEZUMAB-VFRM Form and strength INJECTABLE;INJECTION - 150MG/ML Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2025-08-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview AJOVY is listed in Drugs@FDA under application 761089 (BLA). Review priority: PRIORITY Marketing status: Prescription Active ingredient FREMANEZUMAB-VFRM Form and strength INJECTABLE;INJECTION - 150MG/ML Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2025-08-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.